19/06/2024  17:35:16 Chg. 0.000 Volume Bid03:01:05 Demandez à03:01:05 Capitalisation boursière Dividende Y. Rapport P/E
24.100EUR 0.00% 1.15 Mio.
Chiffrre d'affaires: 27.69 Mio.
23.900Bid taille: 4 24.150Ask la taille: 867 21.84 Mrd.EUR 3.53% -

Description de l'entreprise

Royal Philips is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
 

Conseil d'administration & Conseil de surveillance

PDG
Roy Jakobs
Conseil d'administration
Abhijit Bhattacharya, Willem Appelo, Steve C de Baca, Jeff DiLullo, Marnix van Ginneken, Charlotte Hanneman, Andy Ho, Deeptha Khanna, Bert van Meurs, Edwin Paalvast, Shez Partovi, Heidi Sichien, Julia Strandberg
Conseil de surveillance
Feike Sijbesma, Chua Sock Koong, Liz Doherty, Marc Harrison, Peter Löscher, Indra Nooyi, Sanjay Poonen, David Pyott, Benoît Ribadeau-Dumas, Paul Stoffels, Herna Verhagen
 

Données de l'entreprise

Nom: Koninklijke Philips N.V.
Adresse: Amstelplein 2, Philips Center, Breitner Tower,NL-1070 MX Amsterdam
Téléphone: +31-40-27-91111
Fax: -
Courriel: -
Internet: www.philips.com
Industrie: Industry
Secteur: Mechanical Engineering
Sous-secteur: -
Fin de l'exercice financier: 31/12
Flotte libre: 100.00%
IPO date: -

Relations avec les investisseurs

Nom: Leandro Mazzoni
Téléphone IR: +31-20-59-77-222
IR-Fax: -
E-mail IR: investor.relations@philips.com

Calendrier de l'entreprise

CW 31 | 29/07/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 28/10/2024 Interim Report 3rd Quarter/9 Months
 

Principaux actionnaires

Autres
 
84.05%
BlackRock, Inc.
 
5.19%
Treasury stock
 
4.08%
UBS Group AG
 
3.64%
T. Rowe Price Group Inc.
 
3.04%